摘要
目的比较Mammotome微创活检术(MMIBS)与针吸细胞学检查(FNAC)对乳腺癌诊断的应用价值。方法对68例乳腺癌患者术前行超声引导下MMIBS及FNAC,并对两种方法的诊断价值进行评价。结果68例患者超声显示率为100%。MMIBS阳性率为97.1%,FNAC为72.1%(P>0.05);MMIBS假阴性率为2.9%,FNAC为27.9%(19/68)(P<0.05)。结论FNAC简便、安全、创伤小,但有阳性率较低、漏诊率较高之不足;MMIBS具有高确诊率、低漏诊率、微创之特点,可作为乳腺肿块定性的首选。
Objective To explore the clinical value of mammotome minimally invasive biopsy （MMIBS） vs fine needle aspiration cytology （FNAC） on breast cancer. Methods Sixty - eight cases of breast cancer were subjected to MMIBS and FNAC under the guidance of ultrasound. The diagnostic value of two methods was evaluated. Results The needle positions in 68 patients were all visualized （100%） under the guidance of ultrasound. Among them, the positive rate of MMIBS and FNAC was 97.1% and 72.1% respectively （ P 〉 0.05 ）. The pseudonegative rate of MMIBS and FNAC was 2.9 % and 27.9 % respectively （ P 〈 0.05）. Conclusion FNAC is convenient,safe,microinvasive,but has lower positive rate and higher pseudonegative rate. MMIBS was the characters of micro- invasion, high definitive and low pseudonegative rate. MMIBS was recommended as the first choice of definitive diagnosis for breast cancer.
出处
《临床外科杂志》
2007年第6期402-403,共2页
Journal of Clinical Surgery
